Canada Spends Logo

Explore our Budget 2026 analysis

Grant: CIHR Fellowship

Direct Payment

$150,000.00

Generating Antigen-Specific Immune Memory

FY 2008-09

Summary
Polio, hepatitis B, smallpox - these are but a few diseases for which vaccines have achieved great reductions in disease burden worldwide. However the demand for new vaccines far outweighs the success stories: infectious diseases claim 15 million lives every year. Due to the high-risk nature of live attenuated or genetically modified organism vaccines, subunit vaccines (using a protein subunit of the infectious agent, such as a cell wall component) remain the popular format in current vaccine development. Despite the active use of subunit protein vaccines, the immunological theory behind their application is in its infancy. We still do not fully understand what vaccine components appropriately mobilize cytotoxic "killer" T cells or antibody-producing B cells, nor do we know which conditions elicit long-lasting immune memory. Our project aims to explore a novel aspect of vaccines that may contribute to long-lasting memory, a phenomenon known as antigen persistence. There is convincing evidence that pieces of a subunit vaccine linger long after the vaccination. Moreover, it appears that the persistence of these pieces of vaccine (known as antigen) may directly play a role in promoting the survival of memory T helper cells that are responsible for activating memory B cells and cytotoxic T cells when the host becomes re-infected. We are seeking to uncover which cells are involved in this process of antigen persistence. The effectiveness of a vaccine is often dependent on its adjuvant. An adjuvant is a vaccine component designed to optimize immune system activation during vaccination. Recent research indicates that adjuvants change vaccine outcomes by modulating antigen persistence. Therefore, we propose to test the ability of novel adjuvants to induce antigen persistence. Ultimately, understanding which cells are involved in antigen persistence and learning how to maximize this phenomenon through adjuvants will allow us to create better vaccines.
Program
CIHR Fellowship
Location
California, United States of America
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
180882
Name
Wong Kurt A
Region
California
Country
United States of America
Orgtype
Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Generating Antigen-Specific Immune Memory
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Adjuvant; Antigen Persistence; Flow Cytometry; Immune Memory; Memory B Cells; Memory Th Cells; Subunit Vaccine
Abstract
Polio, hepatitis B, smallpox - these are but a few diseases for which vaccines have achieved great reductions in disease burden worldwide. However the demand for new vaccines far outweighs the success stories: infectious diseases claim 15 million lives every year. Due to the high-risk nature of live attenuated or genetically modified organism vaccines, subunit vaccines (using a protein subunit of the infectious agent, such as a cell wall component) remain the popular format in current vaccine development. Despite the active use of subunit protein vaccines, the immunological theory behind their application is in its infancy. We still do not fully understand what vaccine components appropriately mobilize cytotoxic "killer" T cells or antibody-producing B cells, nor do we know which conditions elicit long-lasting immune memory. Our project aims to explore a novel aspect of vaccines that may contribute to long-lasting memory, a phenomenon known as antigen persistence. There is convincing evidence that pieces of a subunit vaccine linger long after the vaccination. Moreover, it appears that the persistence of these pieces of vaccine (known as antigen) may directly play a role in promoting the survival of memory T helper cells that are responsible for activating memory B cells and cytotoxic T cells when the host becomes re-infected. We are seeking to uncover which cells are involved in this process of antigen persistence. The effectiveness of a vaccine is often dependent on its adjuvant. An adjuvant is a vaccine component designed to optimize immune system activation during vaccination. Recent research indicates that adjuvants change vaccine outcomes by modulating antigen persistence. Therefore, we propose to test the ability of novel adjuvants to induce antigen persistence. Ultimately, understanding which cells are involved in antigen persistence and learning how to maximize this phenomenon through adjuvants will allow us to create better vaccines.
Competitiondate
200902
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Wong, Kurt A
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~